AstraZeneca could leave the London Stock Exchange over dissatisfaction with regulations, which would significantly affect the FTSE 100 index.
Sanziana Georgescu
Economy
sursa foto: unsplash.com
Always see our news on Google
British pharmaceutical company AstraZeneca, with a market capitalization of £161.2 billion, is considering a move to the US stock exchange because of dissatisfaction with UK regulations. The decision could reflect a wider trend in which companies prefer US markets for higher valuations and a bigger investor base. Experts believe AstraZeneca's departure would be a significant loss for the London Stock Exchange, which risks losing its status as a global financial center.
Sources
Latest News
22:58
The Oradea City Hall will turn on the public lighting an hour later to reduce energy consumption.
22:42
Volodymyr Zelensky dismissed Olha Stefanișena from the position of ambassador to the USA, in the context of allegations of embezzlement.
22:30
Switzerland: An outbreak of legionellosis in Basel has led to 26 cases / Authorities suspect cooling towers as the source of contamination
22:18
Unit 2 of the Cernavodă Nuclear Power Plant can operate for only five days due to the decrease in the Danube's water level.
21:57
At Mița, the cyclist turns off the architectural lighting of the facade to reduce energy consumption.
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
.webp)
